Bank Julius Baer & Co
GNTA

Bank Julius Baer & Co’s Genenta Science GNTA Stock Holding History

Bank Julius Baer & Co’s Portfolio GNTA Stock Details GNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-385,313
Closed -$1.44M – 509
2024
Q1 		$1.44M Sell
385,313
-412,547
-52% -$1.69M 0.01% 244
2023
Q4 		$3.47M Buy
797,860
+385,313
+93% +$2M 0.01% 221
2023
Q3 		$2.06M Hold
412,547
– – 0.01% 207
2023
Q2 		$2.46M Buy
+412,547
New +$2.45M 0.01% 198

Other funds holding GNTA

AG
AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return
A
Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank Julius Baer & Co's GNTA Position: Q2 2024 in Review

Bank Julius Baer & Co sold out of Genenta Science (GNTA) in Q2 2024, closing a stake of 385,313 shares — an estimated $1.44M sold.

Bank Julius Baer & Co first reported a position in GNTA in Q2 2023 and held it in 4 quarters. The position peaked at $3.47M in Q4 2023. 5 funds tracked by Wall St. Rank hold GNTA as of Q2 2024.

  • Bank Julius Baer & Co reported no remaining Genenta Science position as of Q2 2024 after selling out during the quarter.
  • Bank Julius Baer & Co sold 385,313 Genenta Science shares in Q2 2024, an estimated $1.44M.
  • Bank Julius Baer & Co first reported a position in Genenta Science in Q2 2023 and held it in 4 quarters.
  • Bank Julius Baer & Co's Genenta Science position peaked at $3.47M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Genenta Science as of Q2 2024.

Based on Bank Julius Baer & Co's 13F filing for Q2 2024, filed 14 Aug 2024.